Over the last few years, dual pieces of federal legislation have attempted to curb costs in the healthcare industry: one aimed at hospitals and another targeting insurers. While the initial efficacy of the rules is yet to be determined, the rules have set a new tone and precedent in the U.S. healthcare industry — namely, that government entities at the federal and state levels are taking a more intentional approach to monitoring and controlling costs impacting consumers. A call for shedding light on price variability, coupled with an industry that is increasingly consumer-focused, is driving greater examination of how hospitals, payors and providers price and charge for care.
A&M Healthcare Industry Group Senior Director, Christina Steiner, discusses hospital and payor price transparency and its market impact in a recent article featured in Corporate Compliance Insights.
Read the full article here
Why Private Equity Works in Value-Based Primary Care
February 2, 2026
Private equity’s influence in value‑based primary care is widely debated, but new evidence shows a different reality. This analysis gives healthcare leaders clarity on where disciplined capital strengthens care models, and where it doesn’t.
The State of Transformation for U.S. Healthcare Providers
January 26, 2026
Market dynamics for health systems are shifting. The most significant driver is the federal Medicaid mandate, which expired at the end of December 2025 and is now pending legislation. This uncertainty is prompting health system leaders to rethink strategy and operations. In this context, we’ll share how other health systems are responding and what these changes mean for organizations like yours.
Strategic Agility for Healthcare Leaders: Building Resilience Amid Disruption
January 12, 2026
The healthcare industry stands at a critical crossroads, grappling with an era of profound disruption and uncertainty. Over the past two decades, the pace of change has accelerated dramatically, reshaping the competitive landscape and challenging the ability of all stakeholders to adapt.
Provider-Sponsored Health Plans: Bridge or Anchor?
December 17, 2025
Provider-sponsored health plans are no longer neutral—they either create enterprise value or drain capital. This analysis gives CFOs and CEOs a clear framework to decide whether to scale, partner, restructure, or exit.
